Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Eva Hoster, Peter Herhaus et al.|The Lancet|2024Cited by 135
ADAR1-mediated RNA editing promotes B cell lymphomagenesisRiccardo Pecori, Qiang Pan‐Hammarström, Karthika-Devi Selvasaravanan et al.|iScience|2023Cited by 24